Status: current, Sufficiently defined by necessary conditions definition status. Date: 31-Jan 2020. Module: SNOMED CT core module
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3787614015 | Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | en | Fully specified name | Active | Only initial character case insensitive | SNOMED CT core module |
| 3788448012 | Interferon alfa-2b (as peginterferon alfa-2b) 50 microgram powder for solution for injection vial | en | Synonym | Active | Only initial character case insensitive | SNOMED CT core module |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Has precise active ingredient | Peginterferon alfa-2b | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | Product containing only peginterferon alfa-2b in parenteral dose form (medicinal product form) | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator unit | microgram | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Has manufactured dose form | Powder for conventional release solution for injection | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Count of base of active ingredient | 1 | false | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength numerator value | 50 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Has unit of presentation | Vial | true | Inferred relationship | Existential restriction modifier | ||
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator value | 1 | false | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Has basis of strength substance | Interferon alfa-2b | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Has presentation strength denominator unit | Vial | true | Inferred relationship | Existential restriction modifier | 1 | |
| Product containing precisely interferon alfa-2b (as peginterferon alfa-2b) 50 microgram/1 vial powder for conventional release solution for injection (clinical drug) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Existential restriction modifier |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
This concept is not in any reference sets
FHIR